Latest Articles about BDX

Alere Beats Earnings Est, Turns to Profit - Analyst Blog

Zacks Equity Research — Fri, 10 May 2013 19:22:16 Z

Alere ( ALR ), a medical products company focused on integrating rapid diagnostics with health management, reported first quarter 2013 adjusted earnings per share of 51 cents beating the

HSIC Misses Earnings Despite Y/Y Gain - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 01:21:01 Z

Henry Schein Inc. ( HSIC ) reported adjusted earnings per share (EPS) of $1.06 in the first quarter of 2013, missing the Zacks Consensus Estimate by a penny, despite 8.2% year over year

Reiterate Becton Dickinson at Neutral - Analyst Blog

Zacks Equity Research — Tue, 07 May 2013 22:22:57 Z

On May 6, we retained Becton, Dickinson and Company ( BDX ) at Neutral based on the performance of the company in fiscal second quarter 2013. Why the Retention? On May 2, Becton

Becton Beats Earnings, Guides High - Analyst Blog

Zacks Equity Research — Thu, 02 May 2013 22:25:29 Z

Medical technology major , Becton, Dickinson and Company ( BDX ) reported second-quarter fiscal 2013 adjusted earnings per share from continuing operations of $1.44, beating the Zacks

Baxter Earnings Beat on EPS, Miss on Rev - Analyst Blog

Zacks Equity Research — Thu, 18 Apr 2013 20:13:47 Z

Baxter International Inc. ( BAX ) reported first quarter adjusted (excluding one-time items) earnings per share of $1.05, thereby beating the Zacks Consensus Estimate of $1.04 and

MedAssets in Partnership with Ariba - Analyst Blog

Zacks Equity Research — Tue, 09 Apr 2013 23:08:28 Z

MedAssets, Inc. ( MDAS ), a company dedicated to revenue cycle management ("RCM") and supply chain management, recently revealed a strategic partnership with the SAP company,

MedAssets Furthers Relationship - Analyst Blog

Zacks Equity Research — Wed, 03 Apr 2013 23:21:46 Z

MedAssets, Inc. ( MDAS ), a company dedicated to revenue cycle management (RCM) and supply chain management, recently revealed a deal with Kettering Health Network of Ohio which will enable

Test Menu Expansion by LabCorp - Analyst Blog

Zacks Equity Research — Wed, 03 Apr 2013 23:21:01 Z

Laboratory Corporation of America Holdings ( LH ) recently launched an expanded testing menu to diagnose, treat and evaluate the course of Inflammatory Bowel Disease (IBD). The expanded

Reiterate DENTSPLY at Neutral - Analyst Blog

Zacks Equity Research — Wed, 03 Apr 2013 22:21:29 Z

On Apr 1, 2013, we retained DENTSPLY International Inc. ( XRAY ) at Neutral after the company beat Zacks Consensus Estimates for earnings and revenue for fourth quarter 2012. Why the

3 Rules for Making 100%-Plus Gains With Biotech Stocks

dsgoodboy@gmail.com (David Goodboy) — Tue, 02 Apr 2013 23:30:00 Z

Biotechstocks are among the riskiestinvestments , but there is also the chance of huge returns. I'm not talking about 25% or even 50% returns on yourinvestment . Returns of 100%-plus are not

Merge introduces Merge OrthoPACS - Analyst Blog

Zacks Equity Research — Fri, 22 Mar 2013 21:28:41 Z

After a disappointing quarter, Merge Healthcare Incorporated ( MRGE ) has witnessed events that favor the company. This series of good news has been encouraging for investors.

Patterson Reiterated at Neutral - Analyst Blog

Zacks Equity Research — Tue, 19 Mar 2013 01:44:06 Z

On Mar 15, we retained Patterson Companies Inc. ( PDCO ) at Neutral, following its third-quarter fiscal 2013 results. Although results were in-line, the company needs to address its

Reiterate Cooper at Neutral - Analyst Blog

Zacks Equity Research — Fri, 15 Mar 2013 22:45:23 Z

On Mar 13, 2013, we retained The Cooper Companies Inc. ( COO ) at Neutral after the company beat Zacks Consensus Estimates for earnings and revenue for fiscal first quarter 2013. Why the

CR Bard Reiterated at Neutral - Analyst Blog

Zacks Equity Research — Thu, 14 Mar 2013 22:11:12 Z

On Mar 13, we retained Neutral recommendation on CR Bard Inc. ( BCR ) following its fourth-quarter results. Despite the upbeat results, the company's organic growth rate, especially in the

HSIC Discusses 2013 Biz Environment - Analyst Blog

Zacks Equity Research — Thu, 14 Mar 2013 00:12:36 Z

Recently, Henry Schein ( HSIC ) reviewed its 2012 performance, discussed competitive dynamics and current business environment during the Barclays Global Healthcare Conference. The company